Vertex Pharmaceuticals (VX1) Q3 2023 Earnings Report
23 Followers
DE:VX1 Q3 2023 EPS Results
- Actual EPS
- EUR 3.63
- Consensus EPS
- EUR 3.50
- Beat/Miss
- Beat by +EUR 0.13
- One Year Ago EPS
- EUR 3.57
DE:VX1 Q3 2023 Revenue Results
- Actual Revenue
- EUR 2.21B
- Expected Revenue
- EUR 2.23B
- Beat/Miss
- Missed by -EUR 18.47M
- YoY Revenue Growth
- +9.33%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/06/2023
- Time
- After Close
- Conference Call
- Monday, November 6, 2023
DE:VX1 Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
DE:VX1 Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VX1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 3.76- | 4.47 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.294.23 | 4.27 | -0.83% (-0.04) | |
| Aug 03, 2026 | 2026 (Q2) | 4.224.21 | 4.02 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.773.98 | 3.61 | 10.10% (+0.36) | |
| Feb 12, 2026 | 2025 (Q4) | 4.554.47 | 3.54 | 26.38% (+0.93) | |
| Nov 03, 2025 | 2025 (Q3) | 4.074.27 | 3.9 | 9.59% (+0.37) | |
| Aug 06, 2025 | 2025 (Q2) | 3.814.02 | -11.41 | 135.23% (+15.43) | |
| May 05, 2025 | 2025 (Q1) | 3.843.61 | 4.23 | -14.71% (-0.62) | |
| Feb 10, 2025 | 2024 (Q4) | 3.573.54 | 3.74 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.633.90 | 3.63 | 7.35% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
